{"title":"Association between Stroke History and Clinical Events in Atrial Fibrillation Patients after Valve Replacement.","authors":"Xinsheng Yan, Shuwen Lian, Dong Wang, Bao Yan, Litao Zhang, Zhenlu Zhang","doi":"10.31083/RCM26992","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The association between stroke history and clinical events after valve replacement in patients with atrial fibrillation (AF) combined with valvular heart disease (VHD) is unclear. Thus, we sought to investigate the relationship between stroke history and clinical events in patients with AF after valve replacement.</p><p><strong>Methods: </strong>This retrospective cohort study enrolled 746 patients with AF who underwent valve replacement between January 2018 and December 2019 at the Wuhan Asia Heart Hospital. Patient information was collected from the hospital's electronic medical record system. Patients were categorized based on their stroke history and followed through outpatient visits or by telephone until the occurrence of an endpoint event; the maximum follow-up period was 24 months. Endpoint events included thrombotic events, bleeding, and all-cause mortality. The frequency of thrombotic, hemorrhagic, and fatal events during the follow-up period was compared between the two groups. Independent risk factors for endpoint events were analyzed using multifactorial Cox regression.</p><p><strong>Results: </strong>The analysis included 746 patients. Over a 24-month follow-up period, there were more total adverse events (hazard ratio (HR) = 2.08, 95% confidence interval (CI) 1.06-4.08, <i>p</i> = 0.018), thrombotic events (HR = 10.28, 95% CI 2.85-37.11, <i>p</i> < 0.001), and increased all-cause mortality (HR = 5.74, 95% CI 1.84-17.93, <i>p</i> < 0.001) in the stroke history group than in the non-stroke history group. Fewer bleeding events were observed in the group with a history of stroke (HR = 0.87, 95% CI 0.37-2.04, <i>p</i> = 0.757). A multifactorial Cox regression analysis revealed that a personal history of stroke was an independent risk factor for total adverse events, thrombotic events, and all-cause mortality.</p><p><strong>Conclusions: </strong>Previous stroke history is significantly associated with adverse events in AF patients following valve replacement.</p>","PeriodicalId":20989,"journal":{"name":"Reviews in cardiovascular medicine","volume":"26 4","pages":"26992"},"PeriodicalIF":1.9000,"publicationDate":"2025-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12059765/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reviews in cardiovascular medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.31083/RCM26992","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Background: The association between stroke history and clinical events after valve replacement in patients with atrial fibrillation (AF) combined with valvular heart disease (VHD) is unclear. Thus, we sought to investigate the relationship between stroke history and clinical events in patients with AF after valve replacement.
Methods: This retrospective cohort study enrolled 746 patients with AF who underwent valve replacement between January 2018 and December 2019 at the Wuhan Asia Heart Hospital. Patient information was collected from the hospital's electronic medical record system. Patients were categorized based on their stroke history and followed through outpatient visits or by telephone until the occurrence of an endpoint event; the maximum follow-up period was 24 months. Endpoint events included thrombotic events, bleeding, and all-cause mortality. The frequency of thrombotic, hemorrhagic, and fatal events during the follow-up period was compared between the two groups. Independent risk factors for endpoint events were analyzed using multifactorial Cox regression.
Results: The analysis included 746 patients. Over a 24-month follow-up period, there were more total adverse events (hazard ratio (HR) = 2.08, 95% confidence interval (CI) 1.06-4.08, p = 0.018), thrombotic events (HR = 10.28, 95% CI 2.85-37.11, p < 0.001), and increased all-cause mortality (HR = 5.74, 95% CI 1.84-17.93, p < 0.001) in the stroke history group than in the non-stroke history group. Fewer bleeding events were observed in the group with a history of stroke (HR = 0.87, 95% CI 0.37-2.04, p = 0.757). A multifactorial Cox regression analysis revealed that a personal history of stroke was an independent risk factor for total adverse events, thrombotic events, and all-cause mortality.
Conclusions: Previous stroke history is significantly associated with adverse events in AF patients following valve replacement.
背景:心房颤动(AF)合并瓣膜性心脏病(VHD)患者瓣膜置换术后卒中史与临床事件的关系尚不清楚。因此,我们试图研究心房颤动患者瓣膜置换术后卒中史与临床事件之间的关系。方法:本回顾性队列研究纳入了2018年1月至2019年12月在武汉亚洲心脏医院接受瓣膜置换术的746例房颤患者。患者信息是从医院的电子病历系统中收集的。根据患者的中风病史对其进行分类,并通过门诊就诊或电话随访,直到发生终点事件;最长随访时间为24个月。终点事件包括血栓事件、出血和全因死亡率。在随访期间比较两组之间血栓、出血和死亡事件的发生频率。终点事件的独立危险因素采用多因素Cox回归分析。结果:共纳入746例患者。在24个月的随访期间,卒中史组的总不良事件(风险比(HR) = 2.08, 95%可信区间(CI) 1.06-4.08, p = 0.018)、血栓形成事件(HR = 10.28, 95% CI 2.85-37.11, p < 0.001)和全因死亡率(HR = 5.74, 95% CI 1.84-17.93, p < 0.001)均高于无卒中史组。卒中史组出血事件较少(HR = 0.87, 95% CI 0.37-2.04, p = 0.757)。多因素Cox回归分析显示,个人卒中史是总不良事件、血栓形成事件和全因死亡率的独立危险因素。结论:既往卒中史与房颤患者瓣膜置换术后不良事件显著相关。
期刊介绍:
RCM is an international, peer-reviewed, open access journal. RCM publishes research articles, review papers and short communications on cardiovascular medicine as well as research on cardiovascular disease. We aim to provide a forum for publishing papers which explore the pathogenesis and promote the progression of cardiac and vascular diseases. We also seek to establish an interdisciplinary platform, focusing on translational issues, to facilitate the advancement of research, clinical treatment and diagnostic procedures. Heart surgery, cardiovascular imaging, risk factors and various clinical cardiac & vascular research will be considered.